Hi, what are you looking for?
Jewish Business News
Search results for "Copaxone"
Money
– Teva’s board is due to meet within days to approve Erez Vigodman’s appointment as CEO. – – Erez Vigodman, 54, a board member...
Money
– Fitch Ratings ranks with Moody’s and S&P and downgraded its debt rating for Teva from “A-” to “BBB+.” – Fitch Ratings has broken...
Financial Research
– Teva sees $3 billion in potential sales by 2020 from 50 new therapeutic entities. – Dr. Michael Hayden – 50 new products with...
Business
– Soros has once again succeeded in raising a few eyebrows on the international market by increasing his holdings in under pressure pharmaceutical giants...
Business
– Perrigo is acquiring Ireland’s Elan, a beneficiary of royalties from rival multiple sclerosis treatment, Tysabri. – – A safety warning by the US...
Financial Research
– JPMorgan has downgraded Teva to “Underweight”, just two months after downgrading it to “Neutral.” – JPMorgan has downgraded Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; TASE: TEVA) to...
Business
– Acting CEO Eyal Desheh / Getty – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) acting CEO Eyal Desheh today said that Copaxone continued to lead...
Money
– Third quarter EPS of $1.27 on revenue of $5.1 billion compares with a consensus estimate of $1.26 on revenue of $5 billion. – ...
Business
– We learned officially today that Jeremy Levin CEO is leaving Teva behind and has resigned.Jewish Business News reported yesterday on a purported row...
Business
– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) is Israel’s largest and most successful public company. As such what it does, and how it thinks, become...